FdaApplication

ANDA 078810

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI ONCOLOGY PLC
application_typeANDA
approval_date2009-08-07

Products (2)

ProductActive ingredientStrengthDosage form
OXALIPLATINOXALIPLATIN100MG/VIALINJECTABLE;INTRAVENOUS
OXALIPLATINOXALIPLATIN50MG/VIALINJECTABLE;INTRAVENOUS

2 products